Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Morath, Christian [VerfasserIn]   i
 Zeier, Martin [VerfasserIn]   i
 Süsal, Caner [VerfasserIn]   i
 Beimler, Jörg [VerfasserIn]   i
 Opelz, Gerhard [VerfasserIn]   i
 Scherer, Sabine [VerfasserIn]   i
 Schmidt, Jan [VerfasserIn]   i
 Macher-Göppinger, Stephan [VerfasserIn]   i
 Klein, Katrin [VerfasserIn]   i
 Sommerer, Claudia [VerfasserIn]   i
 Schwenger, Vedat [VerfasserIn]   i
Titel:Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy
Verf.angabe:Christian Morath; Jörg Beimler; Gerhard Opelz; Sabine Scherer; Jan Schmidt; Stephan Macher-Goeppinger; Katrin Klein; Claudia Sommerer; Vedat Schwenger; Martin Zeier; Caner Süsal
E-Jahr:2012
Jahr:29 February 2012
Umfang:12 S.
Teil:volume:25
 year:2012
 number:5
 pages:506-517
 extent:12
Fussnoten:Gesehen am 07.05.2018
Titel Quelle:Enthalten in: Transplant international
Ort Quelle:Oxford [u.a.] : Wiley-Blackwell, 1988
Jahr Quelle:2012
Band/Heft Quelle:25(2012), 5, Seite 506-517
ISSN Quelle:1432-2277
Abstract:Living donor kidney transplantation in crossmatch-positive patients is a challenge that requires specific measures. Ten patients with positive crossmatch results (n = 9) or negative crossmatch results but strong donor-specific antibodies (DSA; n = 1) were desensitized using immunoadsorption (IA) and anti-CD20 antibody induction. IA was continued after transplantation and accompanied by HLA antibody monitoring and protocol biopsies. After a median of 10 IA treatments, all patients were desensitized successfully and transplanted. Median levels of mean fluorescence intensity (MFI) of Luminex-DSA before desensitization were 6203 and decreased after desensitization and immediately before transplantation to 891. Patients received a median of seven post-transplant IA treatments. At last visit, after a median follow-up of 19 months, 9 of 10 patients had a functioning allograft and a median Luminex-DSA of 149 MFI; serum creatinine was 1.6 mg/dl, and protein to creatinine ratio 0.1. Reversible acute antibody-mediated rejection was diagnosed in three patients. One allograft was lost after the second post-transplant year in a patient with catastrophic antiphospholipid syndrome. We describe a treatment algorithm for desensitization of living donor kidney transplant recipients that allows the rapid elimination of DSA with a low rate of side effects and results in good graft outcome.
DOI:doi:10.1111/j.1432-2277.2012.01447.x
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Kostenfrei: Volltext ; Verlag: http://dx.doi.org/10.1111/j.1432-2277.2012.01447.x
 Kostenfrei: Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1432-2277.2012.01447.x
 DOI: https://doi.org/10.1111/j.1432-2277.2012.01447.x
Datenträger:Online-Ressource
Sprache:eng
Bibliogr. Hinweis:Erscheint auch als : Druck-Ausgabe: Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy. - 2012
Sach-SW:antibody-mediated rejection
 immunoadsorption
 kidney transplantation
 living donor
 positive crossmatch
K10plus-PPN:157400400X
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68249984   QR-Code
zum Seitenanfang